Grimes & Company’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
11,953
-6,954
-37% -$558K 0.02% 253
2026
Q1
$1.58M Buy
18,907
+1,227
+7% +$92.4K 0.04% 195
2025
Q4
$1.19M Buy
17,680
+3,680
+26% +$238K 0.03% 231
2025
Q3
$947K Buy
+14,000
New +$1.01M 0.02% 240

Other funds holding CTVA

Grimes & Company's CTVA Position: Q2 2026 in Review

Grimes & Company reduced its Corteva (CTVA) stake by 37% in Q2 2026, selling an estimated $558K and leaving 11,953 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #253.

Grimes & Company first reported a position in CTVA in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.58M in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Grimes & Company held 11,953 shares of Corteva worth $1.01M as of Q2 2026.
  • Grimes & Company sold 6,954 Corteva shares in Q2 2026, an estimated $558K.
  • Corteva made up 0.02% of Grimes & Company's portfolio in Q2 2026, its #253 holding.
  • Grimes & Company first reported a position in Corteva in Q3 2025 and has held it in 4 quarters since.
  • Grimes & Company's Corteva position peaked at $1.58M in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.